Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 16 Issue: 7, September 2016



Meet Our Editorial Board Member free to download

Volume:16   Issue: 7
Pp: 561-562
Thomas W. Grunt
DOI: 10.2174/156800961607160812205800
Published on: 12 August, 2016



Protein Geranylgeranyltransferase Type 1 as a Target in Cancer

Volume:16   Issue: 7
Pp: 563-571
Nisar Ullah, Muhammad Mansha and Patrick J. Casey
DOI: 10.2174/1568009616666151203224603
Published on: 03 December, 2015



nMET, A New Target in Recurrent Cancer

Volume:16   Issue: 7
Pp: 572-578
Yingqiu Xie, Sholpan Istayeva, Zhanlin Chen, Tursonjan Tokay, Zhaxybay Zhumadilov, Denglong Wu, Gonzalo Hortelano and Jinfu Zhang
DOI: 10.2174/1568009616666160105105250
Published on: 04 January, 2016



RBM15 Functions in Blood Diseases

Volume:16   Issue: 7
Pp: 579-585
Mengyu Hu, Yuxia Yang, Zhi Ji and Jianyuan Luo
DOI: 10.2174/1568009616666160112105706
Published on: 11 January, 2016



Understanding Molecular Pathways and Targets of Brachyury in Epithelial-mesenchymal Transition (EMT) in Human Cancers

Volume:16   Issue: 7
Pp: 586-593
Wenzhe Song and Glenda C. Gobe
DOI: 10.2174/1568009616666160328113338
Published on: 28 March, 2016



Roles of Interferon Regulatory Factors in Chronic Myeloid Leukemia

Volume:16   Issue: 7
Pp: 594-605
Livia Manzella, Elena Tirrò, Maria Stella Pennisi, Michele Massimino, Stefania Stella, Chiara Romano, Silvia Rita Vitale and Paolo Vigneri
DOI: 10.2174/1568009616666160105105857
Published on: 04 January, 2016



BRCA1-Associated Triple-Negative Breast Cancer and Potential Treatment for Ruthenium-Based Compounds

Volume:16   Issue: 7
Pp: 606-617
Khwanjira Hongthong and Adisorn Ratanaphan
DOI: 10.2174/1568009616666160203113957
Published on: 02 February, 2016



MT1-MMP Activation of TGF-β Signaling Enables Intercellular Activation of an Epithelial-mesenchymal Transition Program in Cancer

Volume:16   Issue: 7
Pp: 618-630
Hoang-Lan Nguyen, Pournima Kadam, Alex Helkin, Kevin Cao, Song Wu, Ghassan J. Samara, Qian Zhang, Stanley Zucker and Jian Cao
DOI: 10.2174/1568009616666160216125634
Published on: 16 February, 2016



Persistent GP130/STAT3 Signaling Contributes to the Resistance of Doxorubicin, Cisplatin, and MEK Inhibitor in Human Rhabdomyosarcoma Cells

Volume:16   Issue: 7
Pp: 631-638
Xiaojuan Wu, Hui Xiao, Ruoning Wang, Lingling Liu, Chenglong Li and Jiayuh Lin
DOI: 10.2174/1568009615666150916093110
Published on: 15 September, 2015



Bispecific Antibodies for Targeted Delivery of Dendritic Polyglycerol (dPG) Prodrug Conjugates

Volume:16   Issue: 7
Pp: 639-649
Fatemeh Sheikhi Mehrabadi, Juliane Adelmann, Shilpi Gupta, Stefanie Wedepohl, Marcelo Calderón, Ulrich Brinkmann and Rainer Haag
DOI: 10.2174/1568009616666160208142910
Published on: 08 February, 2016